Skip to main content

Advertisement

SpringerLink
Log in

Haste makes waste: Are the data regarding TARGIT-A IORT ready for prime time?

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Esserman LJ, Alvarado MD, Howe RJ et al (2014) Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat 144(2):371–378

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383(9917):603–613. doi:10.1016/S0140-6736(13)61950-9

    Article  PubMed  Google Scholar 

  3. Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376(9735):91–102

    Article  PubMed  Google Scholar 

  4. Veronesi U, Orecchia R, Maisonneuve P et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269–1277

    Article  PubMed  Google Scholar 

  5. Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805–816

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Leonardi MC, Maisonneuve P, Mastropasqua MG et al (2013) Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol 106(1):21–27

    Article  PubMed  Google Scholar 

  8. Smith GL, Xu Y, Buchholz TA et al (2012) Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 307(17):1827–1837

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Kaidar-Person O, Yarnold J, Offersen BV, Poortmans P (2014) Is current evidence about intraoperative partial breast irradiation sufficient for broad implementation in clinical practice? Eur J Surg Oncol 27. doi:10.1016/j.ejso.2014.03.014

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Oncology, Rambam Health Care Campus, POB 9602, 31096, Haifa, Israel

    Orit Kaidar-Person

  2. Institute Verbeeten, Brugstraat 10, 5042 SB, Tilburg, The Netherlands

    Philip Poortmans

  3. Division of Breast Surgical Oncology, Department of Surgery, Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA

    Suzanne Klimberg

  4. Arkansas Breast Cancer Research Program (ABCRP), Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA

    Suzanne Klimberg

  5. Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    Suzanne Klimberg

  6. Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK

    Joanne Haviland

  7. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

    Birgitte Offersen

  8. St Helens Teaching Hospital, University of Liverpool, St Helens, UK

    Riccardo Audisio

  9. Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK

    John Yarnold

Authors
  1. Orit Kaidar-Person
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Poortmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suzanne Klimberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joanne Haviland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Birgitte Offersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Riccardo Audisio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John Yarnold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orit Kaidar-Person.

Additional information

This letter to the editor refers to the article available at doi:10.1007/s10549-014-2881-2 and a rebuttal letter to this letter to the editor is available at doi:10.1007/s10549-014-3036-1.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaidar-Person, O., Poortmans, P., Klimberg, S. et al. Haste makes waste: Are the data regarding TARGIT-A IORT ready for prime time?. Breast Cancer Res Treat 147, 221–222 (2014). https://doi.org/10.1007/s10549-014-3032-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3032-5

Keywords

Search

Navigation